ArticleScience advances2022

A novel β-catenin/BCL9 complex inhibitor blocks oncogenic Wnt signaling and disrupts cholesterol homeostasis in colorectal cancer.

Helen Tanton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.